Trametinib: Potential therapeutic game-changer for Alzheimer’s disease

FHS
October 4, 2023
10:05 am

Researchers developed the ATRIVIEW® platform to screen for molecules that promote differentiation neural stem cells (NSCs).

FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS | Psychedelic Invest

Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced that Maureen O’Connell has stepped

January 3, 2024

Eculizumab biosimilar by Turgut Ilaclari for Neuromyelitis Optica (Devic’s Syndrome): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 1, 2023

Texas Judge Says States Can Revive Challenge to Abortion Pill Access Nationwide

The Texas judge who previously halted approval of the nation’s most common method of abortion ruled Thursday that three states can move ahead with another

January 18, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.